Bristol-Myers Squibb CompanyNYSE
Historical Stock Data
|52 Week High|
|52 Week Low|
What Analysts Recommend for Pfizer and Bristol-Myers Squibb
This year, Pfizer (PFE) stock has fallen 0.34% and Bristol-Myers Squibb (BMY) stock has fallen 6.48%. Both companies are focused on strengthening their position in the high-growth oncology and immunology markets. Let's take a closer look at each.